Citius Pharmaceuticals, Inc.·4

Nov 12, 5:00 PM ET

MCGRATH DENNIS M 4

4 · Citius Pharmaceuticals, Inc. · Filed Nov 12, 2024

Insider Transaction Report

Form 4
Period: 2024-11-07
Transactions
  • Award

    Stock Option (Right to Purchase Common Stock)

    2024-11-07+125,000125,000 total
    Exercise: $0.38Exp: 2034-11-07Common Stock (125,000 underlying)
Holdings
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $0.70Exp: 2033-10-10Common Stock (75,000 underlying)
    75,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.42Exp: 2033-02-07Common Stock (75,000 underlying)
    75,000
Footnotes (2)
  • [F1]The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
  • [F2]The options are vested in full and exercisable immediately.

Documents

1 file
  • 4
    ownership.xmlPrimary